Johnson & Johnson (JNJ) Tops Q2 EPS by 5c; Reaffirms Guidance
July 19, 2011 7:46 AM
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.28, $0.05 better than the analyst estimate of $1.23. Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.22 billion.
